• Health Blog
  • ABC News interview with A/Prof Karin Ried discussing the NIIM Prostate Cancer Screening Study

ABC News interview with A/Prof Karin Ried discussing the NIIM Prostate Cancer Screening Study

Karin-Ried-ABC

Published On

Thursday 2nd July 2020

Watch the ABC Live TV interview of A/Prof Dr Karin Ried with Andrew Geoghegen – discussing the new prostate cancer test and the second phase of the NIIM research study.

With over 3,300 Australian men dying from Prostate Cancer each year, NIIM has been searching for a more reliable and accurate way to diagnose the disease.

As an extension of our ISET-CTC Test, which is exclusively available in Australia at NIIM, we have used PSA (Prostate) markers to develop a test which has been found a true positive rate of 99% and true negative rate of 97%.

Find out more about NIIM Prostate Cancer Screening Study including the criteria and how to participate in NIIM’s population study for the ISET®-CTC Test for prostate cancer

View the published research:

Ried, K. et al. New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers. Frontiers in Oncology.

Access via https://pubmed.ncbi.nlm.nih.gov/32391268/

There's More to Read

ABC News interview with A/Prof Karin Ried discussing the NIIM Prostate Cancer Screening Study

ABC News interview with A/Prof Karin Ried discussing the NIIM Prostate Cancer Screening Study

Watch the ABC Live TV interview of A/Prof Dr Karin Ried with Andrew Geoghegen – discussing the new prostate cancer...

Happy Autumn for the months of March to May!

Happy Autumn for the months of March to May!

As the seasons change it is a reminder for us to honour mother nature and our body as it adapts...

NIIM Director of Research presents at Symposium

NIIM Director of Research presents at Symposium

On Saturday 26 March, Associate Professor Karin Ried – Director of Research at NIIM, presented at the 12th Urology in...

Friends of NIIM

Sign up to receive the latest NIIM newsletter, containing the latest news,
events, and research directly to your inbox